Niacin, N-3 fatty acids and insulin resistance.
Phase of Trial: Phase IV
Latest Information Update: 30 Apr 2013
At a glance
- Drugs Niacin (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Hypertriglyceridaemia
- Focus Pharmacodynamics; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 27 Jan 2011 Status changed from recruiting to completed.
- 22 Apr 2008 The expected completion date for this trial is now 1 Dec 2008.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History